Solid Biosciences (NASDAQ: SLDB) Climbs 26 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Ultragenyx Pharma (RARE) Tops Q3 EPS by 14c, Revenues BeatOctober 27, 2020 4:45 PM Ultragenyx (RARE), Solid Biosciences (SLDB) Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for DMDOctober 23, 2020 8:02 AM Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular DystrophyOctober 23, 2020 8:01 AM